Alprazolam
NDC Package 0185-0197-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Alprazolam is used to treat anxiety and panic disorders. Marketed by Eon Labs, Inc., this product is identified by NDC 0185-0197 and is authorized under FDA application ANDA077777.

Identification & Billing

NDC Package Code
0185-0197-01
Package Description
100 TABLET, EXTENDED RELEASE in 1 BOTTLE
Product Code
0185-0197
11-Digit Billing Format
00185019701

Clinical Specifications

Proprietary Name
Alprazolam
Dosage Form
-
Usage Information
Alprazolam is used to treat anxiety and panic disorders. It belongs to a class of medications called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA).

Regulatory & Marketing

Labeler Name
Eon Labs, Inc.
FDA Application #
ANDA077777
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-30-2006
End Marketing Date
03-31-2012
Listing Expiration
03-31-2012
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0185-0197). Click a package code to view its specific billing and regulatory data.

0185-0197-05
500 TABLET, EXTENDED RELEASE in 1 BOTTLE
0185-0197-60
60 TABLET, EXTENDED RELEASE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0185-0197-01 identifies a specific commercial package of 100 tablet, extended release in 1 bottle of Alprazolam, labeled by Eon Labs, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Eon Labs, Inc. on June 30, 2006. The current certification is valid through March 31, 2012.

What are the primary indications for this medication?

Alprazolam is used to treat anxiety and panic disorders. It belongs to a class of medications called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA).

How is this Eon Labs, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00185019701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0185-0197-01
11-Digit CMS (5-4-2)
00185-0197-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.